Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 3
2006 1
2008 2
2009 3
2010 10
2011 4
2012 17
2013 21
2014 16
2015 13
2016 15
2017 13
2018 18
2019 15
2020 20
2021 36
2022 27
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of tissue-of-origin of early stage cancers using serum miRNomes.
Matsuzaki J, Kato K, Oono K, Tsuchiya N, Sudo K, Shimomura A, Tamura K, Shiino S, Kinoshita T, Daiko H, Wada T, Katai H, Ochiai H, Kanemitsu Y, Takamaru H, Abe S, Saito Y, Boku N, Kondo S, Ueno H, Okusaka T, Shimada K, Ohe Y, Asakura K, Yoshida Y, Watanabe SI, Asano N, Kawai A, Ohno M, Narita Y, Ishikawa M, Kato T, Fujimoto H, Niida S, Sakamoto H, Takizawa S, Akiba T, Okanohara D, Shiraishi K, Kohno T, Takeshita F, Nakagama H, Ota N, Ochiya T; Project Team for Development and Diagnostic Technology for Detection of miRNA in Body Fluids. Matsuzaki J, et al. Among authors: narita y. JNCI Cancer Spectr. 2023 Jan 3;7(1):pkac080. doi: 10.1093/jncics/pkac080. JNCI Cancer Spectr. 2023. PMID: 36426871 Free PMC article.
Bevacizumab for glioblastoma.
Narita Y. Narita Y. Ther Clin Risk Manag. 2015 Dec 1;11:1759-65. doi: 10.2147/TCRM.S58289. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 26664126 Free PMC article. Review.
Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.
Mishima K, Nishikawa R, Narita Y, Mizusawa J, Sumi M, Koga T, Sasaki N, Kinoshita M, Nagane M, Arakawa Y, Yoshimoto K, Shibahara I, Shinojima N, Asano K, Tsurubuchi T, Sasaki H, Asai A, Sasayama T, Momii Y, Sasaki A, Nakamura S, Kojima M, Tamaru JI, Tsuchiya K, Gomyo M, Abe K, Natsumeda M, Yamasaki F, Katayama H, Fukuda H. Mishima K, et al. Among authors: narita y. Neuro Oncol. 2023 Apr 6;25(4):687-698. doi: 10.1093/neuonc/noac246. Neuro Oncol. 2023. PMID: 36334050 Free PMC article. Clinical Trial.
IDH1/2 mutation detection in gliomas.
Arita H, Narita Y, Yoshida A, Hashimoto N, Yoshimine T, Ichimura K. Arita H, et al. Among authors: narita y. Brain Tumor Pathol. 2015 Apr;32(2):79-89. doi: 10.1007/s10014-014-0197-x. Epub 2014 Jul 10. Brain Tumor Pathol. 2015. PMID: 25008158 Review.
Reverse Engineering Glioma Radiomics to Conventional Neuroimaging.
Kinoshita M, Kanemura Y, Narita Y, Kishima H. Kinoshita M, et al. Among authors: narita y. Neurol Med Chir (Tokyo). 2021 Sep 15;61(9):505-514. doi: 10.2176/nmc.ra.2021-0133. Epub 2021 Aug 6. Neurol Med Chir (Tokyo). 2021. PMID: 34373429 Free PMC article. Review.
Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death.
Yamamoto Y, Sasaki N, Kumagai K, Takeuchi S, Toyooka T, Otani N, Wada K, Narita Y, Ichimura K, Namba H, Mori K, Tomiyama A. Yamamoto Y, et al. Among authors: narita y. Neurol Med Chir (Tokyo). 2018 Jul 15;58(7):296-302. doi: 10.2176/nmc.ra.2018-0040. Epub 2018 Jun 13. Neurol Med Chir (Tokyo). 2018. PMID: 29899179 Free PMC article. Review.
226 results